Eri Otsuka

858 total citations
22 papers, 638 citations indexed

About

Eri Otsuka is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Eri Otsuka has authored 22 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Physiology. Recurrent topics in Eri Otsuka's work include Bone Metabolism and Diseases (10 papers), Nitric Oxide and Endothelin Effects (5 papers) and Bone health and treatments (4 papers). Eri Otsuka is often cited by papers focused on Bone Metabolism and Diseases (10 papers), Nitric Oxide and Endothelin Effects (5 papers) and Bone health and treatments (4 papers). Eri Otsuka collaborates with scholars based in Japan, Netherlands and Sweden. Eri Otsuka's co-authors include Hiromi Hagiwara, Shigehisa Hirose, Akira Yamaguchi, Atsuto Inoue, Michitaka Notoya, Satoshi Kasagi, Yoshihisa Kato, Yoshiharu Hiruma, Mitsuhide Naruse and Yoko Ishihara and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Biochemical and Biophysical Research Communications.

In The Last Decade

Eri Otsuka

22 papers receiving 628 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eri Otsuka Japan 14 346 153 78 68 64 22 638
Jutta Meißner-Weigl Germany 10 322 0.9× 155 1.0× 70 0.9× 43 0.6× 37 0.6× 17 725
Doris Schneider Germany 12 245 0.7× 129 0.8× 108 1.4× 58 0.9× 35 0.5× 18 708
Danielle Callaway United States 10 392 1.1× 116 0.8× 113 1.4× 36 0.5× 64 1.0× 17 629
Dun Hong China 16 309 0.9× 107 0.7× 112 1.4× 102 1.5× 40 0.6× 40 683
Clifford R. Stevens United Kingdom 10 285 0.8× 85 0.6× 53 0.7× 31 0.5× 76 1.2× 11 571
Gaia Palmini Italy 11 328 0.9× 111 0.7× 106 1.4× 66 1.0× 42 0.7× 38 675
Tomoyo Kawakubo‐Yasukochi Japan 14 303 0.9× 87 0.6× 95 1.2× 36 0.5× 74 1.2× 29 588
Lige Song China 10 351 1.0× 109 0.7× 105 1.3× 47 0.7× 45 0.7× 20 564
Takashi Kakimoto Japan 11 329 1.0× 201 1.3× 42 0.5× 84 1.2× 80 1.3× 24 690
Kirk P. Van Ness United States 9 248 0.7× 144 0.9× 225 2.9× 74 1.1× 35 0.5× 10 781

Countries citing papers authored by Eri Otsuka

Since Specialization
Citations

This map shows the geographic impact of Eri Otsuka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eri Otsuka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eri Otsuka more than expected).

Fields of papers citing papers by Eri Otsuka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eri Otsuka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eri Otsuka. The network helps show where Eri Otsuka may publish in the future.

Co-authorship network of co-authors of Eri Otsuka

This figure shows the co-authorship network connecting the top 25 collaborators of Eri Otsuka. A scholar is included among the top collaborators of Eri Otsuka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eri Otsuka. Eri Otsuka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yonesaka, Kimio, Junko Tanizaki, Osamu Maenishi, et al.. (2022). Dynamics of HER3 and its correlated gene expression profile in EGFR-mutated NSCLC tumor treated with EGFR-TKI toward enhancing effectiveness of patritumab deruxtecan (HER3-DXd; U3-1402).. Journal of Clinical Oncology. 40(16_suppl). e21175–e21175. 1 indexed citations
2.
Nakano, Naoko, Yuki Tsuchiya, Souichi Ikeno, et al.. (2017). TMED10 Protein Interferes with Transforming Growth Factor (TGF)-β Signaling by Disrupting TGF-β Receptor Complex Formation. Journal of Biological Chemistry. 292(10). 4099–4112. 18 indexed citations
3.
Nawa, Katsuhiko, et al.. (2013). Discovering small molecules that inhibit adipogenesis and promote osteoblastogenesis: Unique screening and Oncostatin M-like activity. Differentiation. 86(1-2). 65–74. 13 indexed citations
4.
Otsuka, Eri, Hiroyuki Abé, Masaki Aburada, & Makoto Otsuka. (2010). Nondestructive prediction of the drug content of an aspirin suppository by near-infrared spectroscopy. Drug Development and Industrial Pharmacy. 36(7). 839–844. 21 indexed citations
5.
Shimada, Kousei, Satoshi Matsui, Takahiro Yamane, et al.. (2006). Arylamine based cathepsin K inhibitors: Investigating P3 heterocyclic substituents. Bioorganic & Medicinal Chemistry. 14(20). 6807–6819. 12 indexed citations
6.
Shimada, Kousei, Satoshi Matsui, Takahiro Yamane, et al.. (2006). Potent and selective cathepsin K inhibitors. Bioorganic & Medicinal Chemistry. 14(20). 6789–6806. 11 indexed citations
7.
Notoya, Michitaka, Eri Otsuka, Akira Yamaguchi, & Hiromi Hagiwara. (2004). Runx-2 is not essential for the vitamin D-regulated expression of RANKL and osteoprotegerin in osteoblastic cells. Biochemical and Biophysical Research Communications. 324(2). 655–660. 21 indexed citations
8.
Otsuka, Eri, Michitaka Notoya, & Hiromi Hagiwara. (2003). Treatment of Myoblastic C2C12 Cells with BMP-2 Stimulates Vitamin D-induced Formation of Osteoclasts. Calcified Tissue International. 73(1). 72–77. 38 indexed citations
9.
Naruse, Mitsuhide, Eri Otsuka, Yoko Ishihara, Sachiko Miyagawa‐Tomita, & Hiromi Hagiwara. (2003). Inhibition of osteoclast formation by 3-methylcholanthrene, a ligand for arylhydrocarbon receptor: suppression of osteoclast differentiation factor in osteogenic cells. Biochemical Pharmacology. 67(1). 119–127. 30 indexed citations
10.
11.
Otsuka, Eri, et al.. (2000). Nitric oxide accelerates the ascorbic acid-induced osteoblastic differentiation of mouse stromal ST2 cells by stimulating the production of prostaglandin E2. European Journal of Pharmacology. 391(3). 225–231. 34 indexed citations
12.
13.
Inoue, Atsuto, Eri Otsuka, Akihide Kamiya, et al.. (1999). Correlation between Induction of Expression of Biglycan and Mineralization by C-Type Natriuretic Peptide in Osteoblastic Cells. The Journal of Biochemistry. 125(1). 103–108. 15 indexed citations
14.
Hagiwara, Hiroaki, Chihaya Adachi, Atsuto Inoue, et al.. (1999). Ipriflavone Down-Regulates Endothelin Receptor Levels during Differentiation of Rat Calvarial Osteoblast-Like Cells. The Journal of Biochemistry. 126(1). 168–173. 11 indexed citations
15.
Kasagi, Satoshi, et al.. (1999). Effects of nicotine on cultured cells suggest that it can influence the formation and resorption of bone. European Journal of Pharmacology. 383(3). 387–393. 88 indexed citations
16.
Hiruma, Yoshiharu, Atsuto Inoue, Aiko Shiohama, et al.. (1998). Endothelins Inhibit Mineralization of Rat Calvarial Osteoblast-Like Cells. Journal of Cardiovascular Pharmacology. 31. S521–S523. 4 indexed citations
17.
Otsuka, Eri, et al.. (1998). Effects of nitric oxide from exogenous nitric oxide donors on osteoblastic metabolism. European Journal of Pharmacology. 349(2-3). 345–350. 43 indexed citations
18.
Hiruma, Yoshiharu, Atsuto Inoue, Aiko Shiohama, et al.. (1998). Endothelins inhibit the mineralization of osteoblastic MC3T3-E1 cells through the A-type endothelin receptor. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 275(4). R1099–R1105. 27 indexed citations
19.
Takahashi, N., et al.. (1997). Simplified Phosphorus Removal Using Iron Media Submerged in Anaerobic Chamber.. Journal of Japan Society on Water Environment. 20(2). 89–94. 2 indexed citations
20.
Inoue, Atsuto, Eri Otsuka, Yoshiharu Hiruma, et al.. (1996). Stimulation by Retinoids of the Natriuretic Peptide System of Osteoblastic MC3T3-E1 Cells. Biochemical and Biophysical Research Communications. 228(1). 182–186. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jutta Meißner-Weigl Breakdown of academic impact, for papers by Doris Schneider Breakdown of academic impact, for papers by Danielle Callaway Breakdown of academic impact, for papers by Dun Hong Breakdown of academic impact, for papers by Clifford R. Stevens Breakdown of academic impact, for papers by Gaia Palmini Breakdown of academic impact, for papers by Tomoyo Kawakubo‐Yasukochi Breakdown of academic impact, for papers by Lige Song Breakdown of academic impact, for papers by Takashi Kakimoto Breakdown of academic impact, for papers by Kirk P. Van Ness
Rankless by CCL
2026